Atria Investments’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
10,678
+4,241
+66% +$448K 0.01% 1108
2026
Q1
$725K Buy
6,437
+1,147
+22% +$132K 0.01% 1246
2025
Q4
$583K Buy
5,290
+391
+8% +$44.1K 0.01% 1342
2025
Q3
$598K Buy
4,899
+113
+2% +$14.6K 0.01% 1327
2025
Q2
$649K Buy
4,786
+727
+18% +$98.2K 0.01% 1284
2025
Q1
$549K Sell
4,059
-882
-18% -$116K 0.01% 1305
2024
Q4
$680K Sell
4,941
-2,087
-30% -$294K 0.01% 1169
2024
Q3
$966K Buy
7,028
+323
+5% +$41.1K 0.01% 986
2024
Q2
$769K Buy
+6,705
New +$774K 0.01% 1073

Other funds holding INGR

Atria Investments's INGR Position: Q2 2026 in Review

Atria Investments increased its Ingredion (INGR) stake by 66% in Q2 2026, buying an estimated $448K and bringing the position to 10,678 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1108.

Atria Investments first reported a position in INGR in Q2 2024 and has held it in 9 quarters since. 613 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Atria Investments held 10,678 shares of Ingredion worth $1.01M as of Q2 2026.
  • Atria Investments bought 4,241 Ingredion shares in Q2 2026, an estimated $448K.
  • Ingredion made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1108 holding.
  • Atria Investments first reported a position in Ingredion in Q2 2024 and has held it in 9 quarters since.
  • 613 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.